BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22202383)

  • 1. [Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
    Okada K; Fujiwara Y; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2363-5. PubMed ID: 22202383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamazaki M; Nishida T; Doki Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):1996-8. PubMed ID: 19106502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination].
    Fujiwara Y; Doki Y; Takiguchi S; Miyata H; Yamazaki M; Nishida T; Monden M
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1923-5. PubMed ID: 18219854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    J Surg Oncol; 2012 Jan; 105(1):38-42. PubMed ID: 21882194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced gastric cancer with peritoneal dissemination successfully treated with S-1 and intraperitoneal docetaxel administration].
    Narita T; Suzuki A; Hashizume E; Yajima M
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):119-22. PubMed ID: 22241365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
    Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
    Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Yamamoto K; Moon JH; Mori M; Doki Y
    Anticancer Res; 2010 Apr; 30(4):1335-9. PubMed ID: 20530449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
    Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].
    Okada K; Ebisui C; Nushijima Y; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2361-3. PubMed ID: 25731523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1].
    Yamamoto T; Shikano T; Hattori K; Kinoshita T; Hachisuka T; Mori T; Shinohara M; Miyauchi M
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1569-71. PubMed ID: 20716889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.
    Yonemura Y; Canbay E; Li Y; Coccolini F; Glehen O; Sugarbaker PH; Morris D; Moran B; Gonzaletz-Moreno S; Deraco M; Piso P; Elias D; Batlett D; Ishibashi H; Mizumoto A; Verwaal V; Mahtem H
    Eur J Surg Oncol; 2016 Aug; 42(8):1123-31. PubMed ID: 27160355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
    Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of the combination therapy with S-1 plus CDDP intraperitoneal chemotherapy for CY positive cancer patient].
    Ishii Y; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Matsumoto H; Yamaguchi T; Nakano D
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2084-6. PubMed ID: 22202291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
    Yonemura Y; Endou Y; Shinbo M; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Mizuno M; Miura M; Ikeda M; Ikeda S; Nakajima G; Yonemura J; Yuuba T; Masuda S; Kimura H; Matsuki N
    J Surg Oncol; 2009 Sep; 100(4):311-6. PubMed ID: 19697437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of scirrhous gastric cancer with peritoneal dissemination acquiring stable disease over three years by treatment with oral anticancer drug S-1].
    Tanabe D; Kondou K; Uchiyama T; Noda K
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1391-3. PubMed ID: 18701856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery].
    Shirai J; Cho H; Fujikawa H; Iwasaki K; Ogata T; Yoshikawa T; Tsuburaya A; Sujishi K; Yamada T; Osaragi T; Yoneyama K; Kasahara A; Yamamoto Y; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2194-6. PubMed ID: 24394057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.